Brimonidine Tartrate/timolol Maleate Solution/ Drops
Product Images NDC 68462-281

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate/timolol Maleate (NDC 68462-281). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label-5ml (Bottle Label 5ml)

Bottle-label-5ml (Bottle Label 5ml)
This text appears to be a product label for an ophthalmic solution used for eyes only. The product contains Brimonidine Tartrate/Timolol Maleate. It provides contact information and instructions for use.*
FDA Label Image

Carton-label-5ml (Carton Label 5ml)

Carton-label-5ml (Carton Label 5ml)
This is information about a pharmaceutical product called Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, manufactured by SamChunDang Pharmaceutical Co. in Korea and distributed by Glenmark Pharmaceuticals Inc. based in the USA. The product is indicated for eye use only and contains active ingredients brimonidine tartrate 0.2% and timolol 0.5%. It is preserved with benzalkonium chloride and comes with instructions for use, storage, and dosage. The solution is sterile and meant for treating eye conditions. For more information, contact Glenmark Pharmaceuticals Inc. at the provided phone number.*
FDA Label Image

Logo.jpg (Image 02)

FDA Label Image

Brimonidine Tartrate Chemical Structure (Image 1)

FDA Label Image

Timolol Maleate Chemical Structure (Image 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.